TNXP tonixpharma.com: Margin dodolan operasi

Tandha merek Tonix Pharmaceuticals Holding (TNXP)

The Tonix Pharmaceuticals (TNXP) portfolio spans neurology and immunology but remains subject to binary clinical trial risks. Formula synergy is generated through partnerships with US Department of Defense centers. The operating profit margin demonstrates internal efficiency, with the current level of the indicator standing at -436.20. The business relies on the development of vaccines and fibromyalgia treatments for healthcare systems and pharmacy chains.

TNXP - Tingkat bathi operasi Tonix Pharmaceuticals Holding Corp. ing rentang 04.07.2022 - 20.11.2026

Tonix Pharmaceuticals - rincian analitis lan metrik utama (TNXP)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:TNXP, Tonix Pharmaceuticals Inc.
Produk dadi Tonix Pharmaceuticals Holding

Operating margin measures the proportion of profit from core operations relative to total revenue before accounting for financial expenses and taxes. This ratio determines the internal efficiency of the business model and the company's ability to generate cash flow. By analyzing the dynamics of operational efficiency, an investor can discern the real value of assets. For Tonix Pharmaceuticals (TNXP), negative values confirm a critical liquidity deficit, leaving the company dependent on equity offerings to fund drug launches.

Analisis pesaing Tonix Pharmaceuticals

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.